Global Prescription Dermatological Drugs Market Report By Product Type (Anti-acne Drugs ,Anti-aging Drugs ,Dermatitis Drugs ,Hair Loss Drugs ,Psoriasis Drugs ,Skin Cancer Drugs ,Melisma Drugs ,Seborrhea Drugs), By Application (Hospital Pharmacies ,Retail Pharmacies ,Online Pharmacies) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2020-2027

ID:VMR11213978
January 2021
Report Formats:
The global demand for Prescription Dermatological Drugs Market is presumed to reach the valuation of nearly USD XX MN by 2027 from USD XX MN in 2020 with a CAGR of XX% under the study period of 2020 - 2027. 

Prescription dermatological drugs are medications prescribed for various skin disorders like acne, rosacea, skin infections, and psoriasis. The most common drugs include topical steroids, systemic steroids, topical phosphodiesterase type 4 inhibitors, topical immunomodulators, or antihistamine. These drugs either prevent or treat skin disorders and can be used for routine skin care to maintain the skin susceptible to skin disorders. The use of an appropriate, productive, safe, and cost-effective drug for a specific skin condition in the right dose, and formulation at the right time intervals, is crucial. These drugs are available as tablets, capsules, syrup, injections, ointment, etc.

Market Dynamics

The key drivers for this market's growth are the rising number of people affected by skin disorders due to pollution and the surge in skin cancer cases. Growing awareness about dermatological disorders and high disposable income will further propel market growth. Rapid diagnosis and extensive research carried out by pharmaceuticals to provide adequate and appropriate skin disorder therapies will boost market growth. An increase in government and private organizations' investments to develop novel drugs and strategic alliances between organizations to develop economically viable and effective dermatological drugs will be a market booster. The various barriers affecting this market's growth are stringent government regulations, high development costs, lack of awareness, and reimbursement policies. 

The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.

Additionally, these tools also give inclusive assessment of each segment in the global market of prescription dermatological drugs.

Market Segmentation

This section of the prescription dermatological drugs market report  provides detailed data on the segments by analyzing them geographically, thereby assisting the strategist in identifying the target demographics for the respective product or service.

By Product Type 
  • Anti-acne Drugs 
  • Anti-aging Drugs 
  • Dermatitis Drugs 
  • Hair Loss Drugs 
  • Psoriasis Drugs 
  • Skin Cancer Drugs 
  • Melisma Drugs 
  • Seborrhea Drugs 

By Application 
  • Hospital Pharmacies 
  • Retail Pharmacies 
  • Online Pharmacies

Regional Analysis

This section covers regional segmentation which accentuates on current and future demand for Prescription Dermatological Drugs market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.

Global Prescription Dermatological Drugs Market Share by Region (Representative Graph)

Global Prescription Dermatological Drugs Market Share


The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the prescription dermatological drugs market include Johnson & Johnson ,Merck,Bayer ,Mylan Pharmaceuticals,F. Hoffmann-La Roche ,Allergan,Valeant Pharmaceuticals ,PharmaDerm Pharmaceuticals ,Allergan Inamed Corporation,Pfizer. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
 
METHODOLOGY:

This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources,  Technical Journals, Financial Reports, SEC Filings, and other different industry publications. 

If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Market
       2.2. Global Market Snapshot
 
3 . PRESCRIPTION DERMATOLOGICAL DRUGS – INDUSTRY ANALYSIS
       3.1. Introduction - Market Dynamics
       3.2. Market Drivers
       3.3. Market Restraints
       3.4. Opportunities
       3.5. Industry Trends
       3.6. Porter’s Five Force Analysis
       3.7. Market Attractiveness Analysis
           3.7.1 By Product Type
           3.7.2 By Application
           3.7.3 By Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Value Chain Analysis
       4.2. Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Raw Material Manufactures List
           4.2.3. Price Trend of Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
       5.1. Impact Analysis of Covid-19 Outbreak
           5.1.1. Direct Impact on Production
           5.1.2. Supply Chain and Market Disruption
           5.1.3. Financial Impact on Firms and Financial Markets
       5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       5.3. Market: Pre V/S Post COVID-19
       5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
       5.5. COVID-19: Micro and Macro Factor Analysis
 
6 . GLOBAL PRESCRIPTION DERMATOLOGICAL DRUGS MARKET ANALYSIS BY PRODUCT TYPE
       6.1 Overview by Product Type
       6.2 Historical and Forecast Data
       6.3 Analysis by Product Type
       6.4 Anti-acne Drugs  Market by Regions
       6.5 Anti-aging Drugs  Market by Regions
       6.6 Dermatitis Drugs  Market by Regions
       6.7 Hair Loss Drugs  Market by Regions
       6.8 Psoriasis Drugs  Market by Regions
       6.9 Skin Cancer Drugs  Market by Regions
       6.10. Melisma Drugs  Market by Regions
       6.11 Seborrhea Drugs  Market by Regions
 
7 . GLOBAL PRESCRIPTION DERMATOLOGICAL DRUGS MARKET ANALYSIS BY APPLICATION
       7.1 Overview by Application
       7.2 Historical and Forecast Data
       7.3 Analysis by Application
       7.4 Hospital Pharmacies  Market by Regions
       7.5 Retail Pharmacies  Market by Regions
       7.6 Online Pharmacies Market by Regions
 
8 . GLOBAL PRESCRIPTION DERMATOLOGICAL DRUGS MARKET ANALYSIS BY GEOGRAPHY
       8.1. Regional Outlook
       8.2. Introduction
       8.3. North America
           8.3.1. Overview, Historic and Forecast Data
           8.3.2. North America By Segment
           8.3.3. North America By Country
           8.3.4. United State
           8.3.5. Canada
           8.3.6. Mexico
       8.4. Europe
           8.4.1. Overview, Historic and Forecast Data
           8.4.2. Europe by Segment
           8.4.3. Europe by Country
           8.4.4. United Kingdom
           8.4.5. France
           8.4.6. Germany
           8.4.7. Italy
           8.4.8. Russia
           8.4.9. Rest Of Europe
       8.5. Asia Pacific
           8.5.1. Overview, Historic and Forecast Data
           8.5.2. Asia Pacific by Segment
           8.5.3. Asia Pacific by Country
           8.5.4. China
           8.5.5. India
           8.5.6. Japan
           8.5.7. South Korea
           8.5.8. Australia
           8.5.9. Rest Of Asia Pacific
       8.6. Latin America
           8.6.1. Overview, Historic and Forecast Data
           8.6.2. Latin America by Segment
           8.6.3. Latin America by Country
           8.6.4. Brazil
           8.6.5. Argentina
           8.6.6. Peru
           8.6.7. Chile
           8.6.8. Rest of Latin America
       8.7. Middle East & Africa
           8.7.1. Overview, Historic and Forecast Data
           8.7.2. Middle East & Africa by Segment
           8.7.3. Middle East & Africa by Country
           8.7.4. Saudi Arabia
           8.7.5. UAE
           8.7.6. Israel
           8.7.7. South Africa
           8.7.8. Rest Of Middle East And Africa
 
9 . COMPETITIVE LANDSCAPE OF THE PRESCRIPTION DERMATOLOGICAL DRUGS COMPANIES
       9.1. Prescription Dermatological Drugs Market Competition
       9.2. Partnership/Collaboration/Agreement
       9.3. Merger And Acquisitions
       9.4. New Product Launch
       9.5. Other Developments
 
10 . COMPANY PROFILES OF PRESCRIPTION DERMATOLOGICAL DRUGS INDUSTRY
       10.1. Company Share Analysis
       10.2. Market Concentration Rate
       10.3. Johnson & Johnson
           10.3.1. Company Overview
           10.3.2. Financials
           10.3.3. Products
           10.3.4. Recent Developments
       10.4. Merck
           10.4.1. Company Overview
           10.4.2. Financials
           10.4.3. Products
           10.4.4. Recent Developments
       10.5. Bayer
           10.5.1. Company Overview
           10.5.2. Financials
           10.5.3. Products
           10.5.4. Recent Developments
       10.6. Mylan Pharmaceuticals
           10.6.1. Company Overview
           10.6.2. Financials
           10.6.3. Products
           10.6.4. Recent Developments
       10.7. F. Hoffmann-La Roche
           10.7.1. Company Overview
           10.7.2. Financials
           10.7.3. Products
           10.7.4. Recent Developments
       10.8. Allergan
           10.8.1. Company Overview
           10.8.2. Financials
           10.8.3. Products
           10.8.4. Recent Developments
       10.9. Valeant Pharmaceuticals
           10.9.1. Company Overview
           10.9.2. Financials
           10.9.3. Products
           10.9.4. Recent Developments
       10.10. PharmaDerm Pharmaceuticals
           10.10.1. Company Overview
           10.10.2. Financials
           10.10.3. Products
           10.10.4. Recent Developments
       10.11. Allergan Inamed Corporation
           10.11.1. Company Overview
           10.11.2. Financials
           10.11.3. Products
           10.11.4. Recent Developments
       10.12. Pfizer
           10.12.1. Company Overview
           10.12.2. Financials
           10.12.3. Products
           10.12.4. Recent Developments
 
 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • COVID-19 Impact Analysis by Production, Import, Export and Demand
  • Pre V/S Post COVID-19
  • Estimated Impact Of The Coronavirus (Covid-19) Epidemic
  • COVID-19: Micro and Macro Factor Analysis
  • Analysis by Product Type  (USD MN)
  • Anti-acne Drugs  Market by Geography (USD MN)
  • Anti-aging Drugs  Market by Geography (USD MN)
  • Dermatitis Drugs  Market by Geography (USD MN)
  • Hair Loss Drugs  Market by Geography (USD MN)
  • Psoriasis Drugs  Market by Geography (USD MN)
  • Skin Cancer Drugs  Market by Geography (USD MN)
  • Melisma Drugs  Market by Geography (USD MN)
  • Seborrhea Drugs  Market by Geography (USD MN)
  • Analysis Market by Application  (USD MN)
  • Hospital Pharmacies  Market by Geography (USD MN)
  • Retail Pharmacies  Market by Geography (USD MN)
  • Online Pharmacies Market by Geography (USD MN)
  • Global Prescription Dermatological Drugs Market by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton
 
LIST OF FIGURES
 
  • Research Scope of Prescription Dermatological Drugs Report
  • Market Research Process
  • Market Research Methodology
  • Global Prescription Dermatological Drugs Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Product Type
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Product Type  (USD MN)
  • Anti-acne Drugs  Market by Geography (USD MN)
  • Anti-aging Drugs  Market by Geography (USD MN)
  • Dermatitis Drugs  Market by Geography (USD MN)
  • Hair Loss Drugs  Market by Geography (USD MN)
  • Psoriasis Drugs  Market by Geography (USD MN)
  • Skin Cancer Drugs  Market by Geography (USD MN)
  • Melisma Drugs  Market by Geography (USD MN)
  • Seborrhea Drugs  Market by Geography (USD MN)
  • Global Market Analysis by Application  (USD MN)
  • Hospital Pharmacies  Market by Geography (USD MN)
  • Retail Pharmacies  Market by Geography (USD MN)
  • Online Pharmacies Market by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Company Market Share Analysis, 2020
 
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials